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The recent special issue of FEBS Letters devoted to Viral
Ion Channels (552/1, 18 September 2003) described a number
of viral proteins that are thought to have an important role in
the viral life cycle by acting as ion channels in their respective
viruses. The M2 proteins of in£uenza A and B viruses are the
best studied of the viral ion channels, and recent experimental
¢ndings related to these ion channels were reviewed at a work-
shop held in Evanston, IL, USA on 10 November 2003. In-
£uenza presents a severe threat to public health that is only
partially ameliorated by vaccination. Outbreaks of the H5N1
in£uenza virus in 1997 killed six of the 18 infected individuals,
and a highly pathogenic H7N7 avian in£uenza virus spread to
workers in the poultry industry in 2003, killing a veterinarian
and causing infections in poultry workers for which there was
some evidence of spread from human-to-human. Animal res-
ervoirs serve as a constant source of new variant and reassor-
tant viruses that escape immune surveillance [1], and the M2
protein of in£uenza A virus is one of the few antiviral drug
targets that can be inhibited in order to sti£e active in£uenza
infections. It is thus important to study the M2 proteins in
order to realize their potential as antiviral targets.
In£uenza A and in£uenza B are related but phylogenetically
distinct, membrane-bound viruses that encode the small M2
ion channel proteins [2]. These proton channels are found in
the virus membrane and play an essential role in the life cycle
of the virus. In fact, the antiviral drug amantadine inhibits
replication of the in£uenza A virus by inhibiting in£uenza A
M2 proton channel activity. Inhibition occurs by preventing
acidi¢cation of the virus particle while it is contained in the
acidic endosome. Acidi¢cation of the virion is a prerequisite
to viral uncoating; hence, inhibiting the proton channel pre-
vents acidi¢cation, stops uncoating and inhibits replication
(R. Lamb, Northwestern University). Because the pore-lining
residues of the BM2 protein of in£uenza B virus di¡er from
those of the in£uenza A M2 protein [3], the antiviral drug
amantadine is ine¡ective against in£uenza B virus (R.
Lamb), but inhibition of the BM2 protein would be expected
to be e¡ective in inhibiting replication of in£uenza B virus, as
this virus also requires acidi¢cation prior to uncoating [3].
The M2 proteins are attractive models for the study of ion
transport across membranes because they are simple mole-
cules that form homo-oligomers in membranes [4,5] ; the ac-
tive state of the in£uenza A M2 channel is a homotetramer
[6]. The formation of tetramers is quite insensitive to muta-
tions at interfacial residues (A. Stou¡er, University of Penn-
sylvania). The pore-lining residues of the in£uenza A M2
channel have been identi¢ed by a combination of cysteine-
scanning mutagenesis and inhibition with transition elements
[7,8]. These residues are Ala30, Gly34, His37, and Trp41. The
His37 residue acts as both the pH sensor and selectivity ¢lter
and Trp41 acts as the activation gate [9] (L. Pinto, Northwest-
ern University). It is probably no coincidence that naturally
occurring, amantadine-resistant escape mutations occur at the
pore-lining residues Ala30 and Gly34 [10] but one puzzling
escape mutation also occurs at Val27. It was proposed by I.
Arkin (Hebrew University, Jerusalem) on the basis of surface
plasmon resonance measurements that the channel pore might
become widened in escape mutants at this site, permitting
amantadine binding to still occur but be ine¡ective in inhibit-
ing.
Solid-state nuclear magnetic resonance (NMR) measure-
ments of bacterially produced protein (T. Cross and P. Gao,
Florida State University and NHMFL, Tallahassee) con-
¢rmed earlier predictions based on functional studies and
modeling that the transmembrane domain of the in£uenza
A M2 protein forms a helical bundle, each helix of which is
oriented at ca. 25‡ [11] from the perpendicular to the plane of
the membrane (although circular dichroism and FTIR mea-
surements indicated a steeper angle; L. Cristian, University of
Pennsylvania). Speci¢c labeling of the N and O nitrogen atoms
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On 18 September 2003, FEBS Letters devoted a Special Issue to the emerging ¢eld of Viral Ion Channels. That issue contained
12 papers, which addressed the role of virus-encoded ion channels on the viral life cycle, underscoring their advantage towards an
understanding of channel function in terms of protein structure. Four of these papers examined the M2 protein of the in£uenza
virus signifying the impact that this viral ion channel has had in the ¢eld. This FEBS Letters issue was promptly followed by a
workshop held in November 2003 during which a variety of questions related to the M2 proteins of in£uenza A and B viruses were
examined. Pinto and Lamb have summarized below the highlights of the workshop as a ‘follow-up’ to the Viral Ion Channel
Special Issue.
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of His37 allowed the protonation state of these atoms to be
studied as a function of pH and the pKa values for the four
His37 side chains to be determined. The imidazole side chain
of histidine in free solution has a pKa of ca. 6.5, but, as can be
expected, the in£uence of the protein environment within a
lipid bilayer was found to in£uence the pKa of the His37 side
chains of the M2 protein. In addition, the presence of a pos-
itive charge on one histidine probably in£uences the pKa of
the remaining uncharged histidines in the tetramer. Two His37
residues were found to have pKa values near 8, a third near 6
and the fourth close to 4. A model of the proton transfer
reaction with two titratable sites was presented by J. Lear
(University of Pennsylvania). This model was derived from
functional studies of conductance vs. pH [12]. Solid-state
NMR measurements also indicated the presence of an ordered
helical region in the cytoplasmic domain of the in£uenza A
M2 protein that is associated with the inner membrane lea£et
[13]. This ¢nding is in agreement with functional ¢ndings with
truncation mutations and with the resistance to tryptic diges-
tion of residues 44^60 of the cytoplasmic domain [14].
A ready supply of functional protein is essential to all so-
phisticated structural and biophysical studies. P. Gao reported
on a method for the synthesis and refolding of ca. 50 mg
quantities of the in£uenza A M2 monomer in Escherichia
coli and D. Busath (Brigham Young University) reported on
functional reconstitution of this protein in vesicles and bi-
layers; complete inhibition by amantadine was reported for
the former but not the latter preparation. Homotetrameric
proteins present an inherent di⁄culty for interpretation of
functional studies because it is not possible to identify which
subunit of the tetramer is altered by a particular manipula-
tion. A solution to this problem was presented by G. Kochen-
doerfer (Gryphon Therapeutics, South San Francisco) who
outlined the total chemical synthesis of subunits of the M2
protein [14] and demonstrated how subunits can be assembled
on a template to which the ectodomain of each subunit is
anchored [15]. This approach would allow just one of the
subunits to be modi¢ed at a time, in a controlled fashion.
This meeting made it clear that the minimalistic M2 ion
channel proteins are a valuable resource for the study of ion
transport mechanisms. Uncertainty remains about the role of
each of the four transmembrane domain histidine residues and
the orientation of the cytoplasmic helices of the in£uenza A
M2 protein relative to the membrane. Great strides in under-
standing the function of the M2 ion channel protein will result
from knowledge of the structure of the protein. Solid-state
NMR was revealed to be particularly well-suited to the study
of these membrane proteins because this approach directly
reports interactions between the relevant ion, the proton,
and the atoms of the transporting channel protein. Finally,
further knowledge of the structure^function relationship of
these two channels will probably allow e¡ective inhibitors to
be designed for each of them, providing us with needed anti-
viral agents that act against in£uenza virus.
References
[1] Webby, R.J. and Webster, R.G. (2003) Science 302, 1519^1522.
[2] Lamb, R.A. and Krug, R.M. (2001) in: Field’s Virology (Knipe,
D.M. and Howley, P.M., Eds.), pp. 1487^1531, Lippincott, Wil-
liams and Wilkins, Philadelphia, PA.
[3] Mould, J.A., Paterson, R.G., Takeda, M., Ohigashi, Y., Venka-
taraman, P., Lamb, R.A. and Pinto, L.H. (2003) Dev. Cell 5,
175^184.
[4] Holsinger, L.J. and Lamb, R.A. (1991) Virology 183, 32^43.
[5] Paterson, R.G., Takeda, M., Ohigashi, Y., Pinto, L.H. and
Lamb, R.A. (2003) Virology 306, 7^17.
[6] Sakaguchi, T., Tu, Q., Pinto, L.H. and Lamb, R.A. (1997) Proc.
Natl. Acad. Sci. USA 94, 5000^5005.
[7] Shuck, K., Lamb, R.A. and Pinto, L.H. (2000) J. Virol. 74, 7755^
7761.
[8] Gandhi, C.S., Shuck, K., Lear, J.D., Dieckmann, G.R., DeGra-
do, W.F., Lamb, R.A. and Pinto, L.H. (1999) J. Biol. Chem. 274,
5474^5482.
[9] Tang, Y., Zaitseva, F., Lamb, R.A. and Pinto, L.H. (2002)
J. Biol. Chem. 277, 39880^39886.
[10] Hay, A.J. (1985) EMBO J. 4, 3021^3024.
[11] Tian, C., Tobler, K., Lamb, R.A., Pinto, L.H. and Cross, T.A.
(2002) Biochemistry 41, 11294^11300.
[12] Chizhmakov, I.V., Geraghty, F.M., Ogden, D.C., Hayhurst, A.,
Antoniou, M. and Hay, A.J. (1996) J. Physiol. 494, 329^336.
[13] Tian, C., Gao, P.F., Pinto, L.H., Lamb, R.A. and Cross, T.A.
(2003) Protein Sci. 12, 2597^2605.
[14] Kochendoerfer, G.G., Salom, D., Lear, J.D., Wilk-Orescan, R.,
Kent, S.B. and DeGrado, W.F. (1999) Biochemistry 38, 11905^
11913.
[15] Kochendoerfer, G.G., Tack, J.M. and Cressman, S. (2002) Bio-
conjug. Chem. 13, 474^480.
FEBS 28114 16-2-04
L.H. Pinto, R.A. Lamb/FEBS Letters 560 (2004) 1^22
